Cargando…
Reduced mu opioid receptor availability in schizophrenia revealed with [(11)C]-carfentanil positron emission tomographic Imaging
Negative symptoms, such as amotivation and anhedonia, are a major cause of functional impairment in schizophrenia. There are currently no licensed treatments for negative symptoms, highlighting the need to understand the molecular mechanisms underlying them. Mu-opioid receptors (MOR) in the striatum...
Autores principales: | Ashok, Abhishekh H., Myers, Jim, Reis Marques, Tiago, Rabiner, Eugenii A., Howes, Oliver D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776653/ https://www.ncbi.nlm.nih.gov/pubmed/31582737 http://dx.doi.org/10.1038/s41467-019-12366-4 |
Ejemplares similares
-
Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [(11)C]-carfentanil PET and fMRI study
por: Shatalina, Ekaterina, et al.
Publicado: (2023) -
Acute acetate administration increases endogenous opioid levels in
the human brain: A [(11)C]carfentanil molecular imaging
study
por: Ashok, Abhishekh H, et al.
Publicado: (2021) -
O5.5. THE NEUROBIOLOGY OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: MULTI-MODAL PET AND FMRI FINDINGS
por: Howes, Oliver, et al.
Publicado: (2020) -
GABA-A receptor differences in schizophrenia: a positron emission tomography study using [(11)C]Ro154513
por: Marques, Tiago Reis, et al.
Publicado: (2020) -
[(11)C]carfentanil PET imaging for studying the peripheral opioid system in vivo: effect of photoperiod on mu-opioid receptor availability in brown adipose tissue
por: Sun, Lihua, et al.
Publicado: (2022)